Funding for this research was provided by:
Svenska Forskningsrådet Formas (2008-5829, 2009-3724, 2016-01111)
The Stockholm County Council (20150224, 20140011)
The Swedish National Heart and Lung Foundations (2015-0558)
the Swedish Brain Foundation (2015-0020, 2017-0203)
Text and Data Mining valid from 2018-08-08
Received: 19 March 2018
Accepted: 12 July 2018
First Online: 8 August 2018
Ethics approval and consent to participate
: This study was performed in accordance with the tenets of the declaration of Helsinki 1975 and its revision in 1983 and European Community guidelines. The regional ethics committees at the Karolinska Institutet and the Stockholm County approved the study (Dnr 98-246, 2003-174, 2011/1891-31). Informed written consent was obtained from the parents of the enrolled patients.
: Not applicable
: Dr. Herlenius is employed by the Karolinska University Hospital and the Karolinska Institutet and is also co-inventor of a patent application regarding biomarkers and their relation to breathing disorders (Patent Application No. WO2009063226). None of the other authors have a conflict of interest related to the study.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.